Gary Sender Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gary Sender.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gary Sender. Gary Sender is Director in Schrodinger, Inc. ($SDGR) and Chief Financial Officer in Nabriva Therapeutics AG ($NBRV) and Chief Financial Officer in Nabriva Therapeutics Plc ($NBRV) and Director in Harmony Biosciences Holdings, Inc. ($HRMY).
Latest Insider Trading Transactions of Gary Sender
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HRMY, NBRV, NBRV, SDGR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2021 | SDGR | Schrodinger, Inc. | Sender Gary | Director | Option Exercise | M | 17.00 | 12,890 | 219,130 | 19 | |
| Mar 10 2021 | SDGR | Schrodinger, Inc. | Sender Gary | Director | Option Exercise | M | 5.31 | 15,885 | 84,349 | 24,246 | |
| Mar 10 2021 | SDGR | Schrodinger, Inc. | Sender Gary | Director | Sell | S | 66.55 | 28,775 | 1,914,838 | 0 | 28.8 K to 0 (-100.00 %) |
| Mar 10 2021 | SDGR | Schrodinger, Inc. | Sender Gary | Director | Buy | M | 17.00 | 12,890 | 219,130 | 28,775 | 15.9 K to 28.8 K (+81.15 %) |
| Mar 10 2021 | SDGR | Schrodinger, Inc. | Sender Gary | Director | Buy | M | 5.31 | 15,885 | 84,349 | 15,885 | 0 to 15.9 K |
| Feb 02 2021 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 2.62 | 37 | 97 | 20,503 | 20.5 K to 20.5 K (-0.18 %) |
| Jan 05 2021 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 2.42 | 32 | 77 | 20,540 | 20.6 K to 20.5 K (-0.16 %) |
| Nov 02 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 0.50 | 312 | 155 | 206,040 | 206.4 K to 206 K (-0.15 %) |
| Oct 01 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 0.53 | 312 | 166 | 206,352 | 206.7 K to 206.4 K (-0.15 %) |
| Sep 02 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 0.62 | 312 | 193 | 206,664 | 207 K to 206.7 K (-0.15 %) |
| Aug 21 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | M | 0.00 | 11,250 | 0 | 0 | |
| Aug 21 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 0.65 | 3,204 | 2,075 | 206,976 | 210.2 K to 207 K (-1.52 %) |
| Aug 21 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Buy | M | 0.00 | 11,250 | 0 | 210,180 | 198.9 K to 210.2 K (+5.66 %) |
| Aug 20 2020 | HRMY | Harmony Bioscience ... | Sender Gary | Director | Option Exercise | A | 24.00 | 16,583 | 397,992 | 16,583 | |
| Aug 04 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 0.76 | 312 | 237 | 198,930 | 199.2 K to 198.9 K (-0.16 %) |
| Jun 03 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 1.14 | 312 | 356 | 199,554 | 199.9 K to 199.6 K (-0.16 %) |
| May 04 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 0.55 | 301 | 165 | 193,679 | 194 K to 193.7 K (-0.16 %) |
| Apr 02 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 0.58 | 301 | 173 | 193,980 | 194.3 K to 194 K (-0.15 %) |
| Mar 03 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 1.35 | 301 | 406 | 194,281 | 194.6 K to 194.3 K (-0.15 %) |
| Feb 10 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 1.35 | 210,000 | 283,500 | 210,000 | |
| Feb 10 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Grant | A | 0.00 | 105,000 | 0 | 183,669 | 78.7 K to 183.7 K (+133.47 %) |
| Feb 04 2020 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 1.35 | 4,295 | 5,798 | 78,669 | 83 K to 78.7 K (-5.18 %) |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 0.00 | 52,500 | 0 | 52,500 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 0.00 | 138,200 | 0 | 138,200 | |
| May 23 2018 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Buy | P | 4.57 | 2,000 | 9,140 | 6,200 | 4.2 K to 6.2 K (+47.62 %) |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 0.00 | 22,500 | 0 | 22,500 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Sep 26 2017 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Buy | P | 8.21 | 2,000 | 16,420 | 4,200 | 2.2 K to 4.2 K (+90.91 %) |
| Jun 28 2017 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | J | 0.00 | 113,000 | 0 | 113,000 | |
| Jun 28 2017 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | J | 0.00 | 88,800 | 0 | 88,800 | |
| Jun 28 2017 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Buy | J | 0.00 | 2,200 | 0 | 2,200 | 0 to 2.2 K |
| Feb 09 2017 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 0.00 | 11,300 | 0 | 11,300 |
Page: 1